HomeRMTI • NASDAQ
add
Rockwell Medical Inc
Previous close
$0.84
Day range
$0.81 - $0.87
Year range
$0.78 - $2.41
Market cap
32.28M USD
Avg Volume
278.46K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Revenue | 15.93M | -43.75% |
Operating expense | 3.86M | -10.39% |
Net income | -1.75M | -205.35% |
Net profit margin | -11.01 | -287.24% |
Earnings per share | — | — |
EBITDA | -1.04M | -141.95% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 23.71M | 29.74% |
Total assets | 57.49M | 0.70% |
Total liabilities | 20.47M | -26.77% |
Total equity | 37.02M | — |
Shares outstanding | 39.41M | — |
Price to book | 0.90 | — |
Return on assets | -7.19% | — |
Return on capital | -8.38% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Net income | -1.75M | -205.35% |
Cash from operations | -1.31M | -130.57% |
Cash from investing | -4.31M | 29.50% |
Cash from financing | 6.74M | 191.57% |
Net change in cash | 1.13M | 137.47% |
Free cash flow | -1.72M | -155.34% |
About
Rockwell Medical Inc. is a publicly traded pharmaceutical company based in Wixom, Michigan and founded in 1996 that focuses on development and commercialization of treatments against diseases such as end-stage renal disease and chronic kidney disease.
The company's primary customers are dialysis providers. Wikipedia
Founded
1996
Headquarters
Website
Employees
244
